Mia's Feed
Medical News & Research

Artificial Intelligence Enhances Breast Cancer Detection in Screening Mammograms

Artificial Intelligence Enhances Breast Cancer Detection in Screening Mammograms

Share this article

Artificial intelligence shows promise in detecting one-third of interval breast cancers missed during screening, potentially reducing aggressive cancers diagnosed between exams.

2 min read

A recent study published in the journal Radiology reveals that artificial intelligence (AI) can significantly improve the detection of interval breast cancers—those diagnosed between regular screening exams. The research indicates that AI algorithms have the potential to identify approximately one-third of these cases that are often missed during initial screening, potentially reducing the number of cancers diagnosed symptomatically later.

Interval breast cancers tend to have poorer outcomes because they are typically more aggressive and grow rapidly. Digital breast tomosynthesis (DBT), also known as 3D mammography, has improved visualization of breast tissue, making it easier to spot cancers obscured in dense tissue. However, despite its advanced imaging capabilities, some cancers remain undetected.

In the study, researchers retrospectively analyzed 224 interval cancers from a total of 1,376 cases. They employed a sophisticated AI algorithm (Lunit INSIGHT DBT v1.1.0.0) and found that it accurately localized 32.6% of these previously missed cancers. Notably, the cancers detected by AI were generally larger and more likely to involve lymph nodes, suggesting that AI might be especially effective at identifying more aggressive tumors.

The study highlights that AI's benefit extends beyond simple detection. It correctly localized cancer sites with high precision, emphasizing its role as a second reader in screening workflows. Dr. Manisha Bahl, a leading researcher, explained that this lesion-level accuracy offers a more realistic measure of AI's clinical performance compared to exam-level assessments.

This pioneering research suggests that integrating AI into screening processes could greatly enhance early detection, reduce interval cancer rates, and potentially save lives by catching cancers when they are more treatable. Nonetheless, further validation in diverse clinical settings is necessary to fully understand its impact on long-term outcomes.

Source: https://medicalxpress.com/news/2025-07-ai-interval-breast-cancers-screening.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Research Connects COVID-19 and Bacterial Infections to Alzheimer's Disease Development

Recent studies reveal that infections like COVID-19 and bacterial agents may contribute to Alzheimer's disease through inflammation and neural invasion, opening new avenues for prevention and therapy.

Bystander T Cells Enhance the Effectiveness of Bispecific Antibody Therapy in Cancer Treatment

New research emphasizes the role of bystander T cells in enhancing the effectiveness of bispecific antibody therapy in lymphoma treatment, potentially improving patient outcomes through sequential CAR-T and BsAb approaches.

Innovative Pipeline for Universal Vaccines Could Broaden Protection Against SARS-CoV-2 Variants and Other Viruses

A new research pipeline aims to develop universal vaccines targeting conserved viral regions, potentially protecting against SARS-CoV-2 variants and other viruses, enhancing pandemic preparedness.

How Restricted Blood Flow Accelerates Tumor Growth by Accelerating Immune Aging

New research shows that restricted blood flow accelerates tumor growth by promoting immune system aging, highlighting the importance of vascular health in cancer prevention.